Intriguingly, Alix has independently been identified as a possible plasma marker for AD as its level was significantly reduced by around 50% in the cortex and 60% in the hippocampus in an Alzheimer’s mouse model as well as plasma from patients [29]. Here, PDCD6IP is linked to Alzheimer disease.